Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Korro Bio Inc (KRRO)

Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Korro Bio, Inc. Receives Approval to Initiate Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency Quiver Quantitative, Inc. - Thu Nov 21, 4:48PM CST

Korro Bio's REWRITE study will assess KRRO-110 for safety and efficacy in treating AATD with participant dosing starting 2025.Quiver AI SummaryKorro Bio, Inc. has announced the approval for its Phase 1/2a...

KRRO : 43.67 (+1.28%)
Korro to Participate in Upcoming Investor Conferences GlobeNewswire - Thu Nov 21, 3:01PM CST

KRRO : 43.67 (+1.28%)
Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency GlobeNewswire - Thu Nov 21, 6:30AM CST

KRRO : 43.67 (+1.28%)
Korro to Present at the Jefferies London Healthcare Conference GlobeNewswire - Thu Nov 14, 7:00AM CST

KRRO : 43.67 (+1.28%)
Korro Reports Third Quarter 2024 Financial Results and Provides Business Updates GlobeNewswire - Tue Nov 12, 3:05PM CST

KRRO : 43.67 (+1.28%)
Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board GlobeNewswire - Mon Nov 4, 6:25AM CST

KRRO : 43.67 (+1.28%)
Author
3 Stocks That Could Rise on European Bank Interest Rate Cuts MarketBeat - Sun Sep 22, 6:00AM CDT

The European Central Bank cut interest rates for the second time in about three months prior the FOMC's interest rate announcement, European stocks may benefit.

NVDA : 134.70 (+3.08%)
AVGO : 220.79 (+1.13%)
NVO : 85.00 (-17.83%)
KRRO : 43.67 (+1.28%)
IFNNY : 32.7100 (-0.70%)
ASML : 705.68 (-0.64%)
Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks Motley Fool - Thu Sep 19, 5:50AM CDT

This strategic play will take time to pay off, but it could keep growth going.

NVO : 85.00 (-17.83%)
KRRO : 43.67 (+1.28%)
MRNA : 39.39 (-0.43%)
Target: Fiscal Q2 Earnings Snapshot AP - Wed Aug 21, 5:35AM CDT

Target: Fiscal Q2 Earnings Snapshot

KRRO : 43.67 (+1.28%)
These 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024? Motley Fool - Sat Dec 2, 2023

These stocks are coming off a banner month, but what about the road ahead?

KRRO : 43.67 (+1.28%)
GYRE : 11.14 (+4.50%)
IXHL : 1.6800 (-5.88%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot